Harmine --- DYRK1A Inhibitor


Catalog No. size PriceQuantity
M60241-5S 5 mg solid $79
M60241-10S 10 mg solid $324

Description

Harmine is a potent, selective and orally bioavailable DYRK1A inhibitor with IC50 of 80 nM. It inhibits phosphorylation of tau directly by DYRK1A (IC50 ~700 nM). It has >10-fold selectivity over DYRK3 and DYRK2 (IC50 ~800 nM and 900 nM respectively. Harmine is also a unique regulator of PPARγ expression that acts by inhibiting the Wnt signalling pathway in a cell-specific manner. It attenuates inflammatory gene expression (TNFα, IL-1β, iNOS) and macrophage accumulation in adipose tissue. Administration of harmine (30 mg/kg) to obese db/db mice resulted in reduced blood glucose, free fatty acids, and triglyceride levels, delayed hyperglycemia, and improved insulin sensitivity. Being function as a new class of human beta cell mitogenic compound, by using three different mouse and human islet in vivo-based models, harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control. The nuclear factors of activated T cells (NFAT) family of transcription factors are defined as likely mediators of human beta cell proliferation and differentiation.

Product information

CAS Number: 442-51-3

Molecular Weight: 212.25

Formula: C13H12N2O

Chemical Name: 7-methoxy-1-methyl-9H-pyrido[3,4-b]indole

Smiles: CC1=NC=CC2=C1NC1=CC(=CC=C21)OC

InChiKey: BXNJHAXVSOCGBA-UHFFFAOYSA-N

InChi: InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3

Technical Data

Appearance: Solid Power.

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO up to 100 mM

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined.

HS Tariff Code: 382200

How to use

In Vitro:

Harmine was used at 10 µM final concentration in various in vitro assays.

In Vivo:

Harmine was dosed orally to obese db/db mice at 30 mg/kg. Harmine was dosed by intraperitoneal injection at 10 mg/kg in mouse partial pancreatectomy model (PPX), Euglycemic human islet transplantation model and diabetic marginal mass human islet transplantation model.

References:

  1. Bain J, et al. The selectivity of protein kinase inhibitors: a further update. (2007) Biochem J. 408(3):297-315.
  2. Waki H, et al. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. (2007) Cell Metab. 5(5):357-70.
  3. Egusa H, et al. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells. (2011) Bone. 49(2):264-74.

Products are for research use only. Not for human use.


Documents

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed